CompletedNot applicableNCT00637533

A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.

Studying Complex regional pain syndrome type 1

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Ian R Carroll
Stanford University
Intervention
Lumbar sympathetic block with Botulinum Toxin type A(procedure)
Enrollment
10 enrolled
Eligibility
21-80 years · All sexes
Timeline
20042007

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00637533 on ClinicalTrials.gov

Other trials for Complex regional pain syndrome type 1

Additional recruiting or active studies for the same condition.

See all trials for Complex regional pain syndrome type 1

← Back to all trials